SUMMARY An antiglobulin reagent containing anti-IgG, -C4c, -C4d, -C3c, and -C3d was used to test red blood cells from healthy subjects and from patients in hospital. In tests read macroscopically on opal tiles, no positive reactions were found in the healthy subjects. Positive reactions were, however, observed in 7 % of the hospital patients. Further tests with monospecific reagents showed the positive reactions to be due to the presence of C4d and C3d on the red cells. All patients with positive antiglobulin reactions had serious disease, in most cases associated with abnormal antibody production or abnormal immunoglobulin levels.
The usefulness of incorporating anticomplement reagents into antiglobulin sera is currently under review, and the optimal characteristics of such polyspecific antisera are under re-assessment (Chaplin, 1973; Beck and Marsh, 1977; Lacey and Cubbin, 1977; Petz and Garratty, 1978) . There is general agreement that antiglobulin sera designed for the detection of red cell sensitisation in vivo, that is, by the direct antiglobulin test, should contain anticomplement antibody-in particular, anti-C3d. There have been several reports in the literature describing false-positive reactions in direct antiglobulin testing using polyspecific antisera (Garratty and Petz, 1971; Issitt et al., 1974; Beck et al., 1976) . Garratty and Petz (1976) showed that when red cells from refrigerated clots were tested, the majority of false-positive reactions (noted in up to 66% of samples tested) were due to anti-C4. Red cells from refrigerated anticoagulated samples gave negative results in direct antiglobulin tests. Stratton and Rawlinson (1974) suggested that the false-positive reactions observed may be a reflection of the potency of the anticomplement sera and that dilution of the antibody might minimise the problem. Other authors (Issitt et al., 1974; Beck et al., 1976) have shown that some false-positive reactions in direct antiglobulin testing may be due to anti-species antibodies. The following study was undertaken to estimate the frequency of false-positive direct antiglobulin reactions in healthy subjects and in random hospital patients.
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CELLS AND SERA
Blood samples from normal, healthy subjects were obtained from blood donors and from laboratory personnel. Blood samples from hospital patients were collected consecutively from samples submitted for routine blood counts. For EDTA samples, 4 ml of blood were added to 6 mg K2EDTA and mixed well. For CPD samples, 1 ml blood was added to 2 ml CPD solution, and for ACD samples 1 vol blood was added to 0 3 vol ACD solution (NIH Solution A). The CPD and ACD solutions were prepared as described by Mollison (1972, pp. 686, 687) . ANTIGLOBULIN SERA Anti-C4c and anti-C3b/c were purchased from Hoechst-Behringwerke Pharmaceuticals and used at a 1: 50 dilution. The methods of preparation, characteristics, and anti-C3d antibody concentrations of R72 anti-C4d/3d, R84 anti-C3c/3d, R356 anti-C3d, and ZARCS monkey anti-C4d reagents have been described previously (Freedman and Mollison, 1976; Freedman et ol., 1977; Chaplin et al., 1977) . The reagents containing anti-C3d were used at anti-C3d antibody concentrations of [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] (Mollison, 1972) . Serum immunoglobulins and C3 and C4 levels were determined by radial immunodiffusion, and antinuclear antibody was tested by immunofluorescence.
Results

TESTS ON NORMAL SUBJECTS
The red cells from 200 EDTA blood samples, maintained at 23°C, from healthy blood donors were tested within 6 hours of collection for the presence of bound complement or IgG. No sample was agglutinated by the cocktail antiserum (anti-C4d/3d, anti-C4c, and anti-C3b/c) or by monospecific antiIgG. Fifteen of the above EDTA samples were maintained in their own serum at 4°C, and aliquots were removed daily for direct antiglobulin testing with the cocktail antiserum. No :C3d/4d cells trypsinised LIS cells (Freedman and Mollison, 1976) . 
Discussion
The results support the previous suggestion (Garratty and Petz, 1976) (Dacie et al., 1957; Garratty and Petz, 1971) . The test NIC-cells prepared in this study showed equally strong agglutination with anti-C3 and anti-C4 reagents, for example, 2+ agglutination with antiC4c and anti-C3b/c, and 3 + agglutination with anti-C4d and anti-C3d. The relative strength of the reactions probably reflects the relative potencies of the respective antisera: the anti-C3d serum used in this study gave a twofold higher agglutination titre against control C3d/4d cells than did the anti-C4d serum. In no case was C4d detected on the red cells in the absence of C3d. Dacie and Worlledge (1969) reported positive direct antiglobulin reactions using anticomplement sera in 8 % of random hospital patients. In the current study, EDTA-treated red cells from 7 % of hospital patients gave positive direct antiglobulin tests with anticomplement sera. Although in no case was a positive result suspected before the test, nor was a definite aetiology evident, the positive reactions may not represent false-positive reactions as such, since none of the 200 normal healthy subjects gave positive tests. In three out of six cases, subsequent testing revealed elevated serum immunoglobulins. In two out of six patients (cases A and F) the positive antiglobulin reactions may represent additional evidence for autoimmune disease. In patient E, the positive result may indicate complement sensitisation after transfusion and may represent an otherwise undetected transfusion incompatibility. None of the patients had overt haemolysis, and it does not appear possible to distinguish between these 'unexplained' positive antiglobulin tests without overt haemolysis and those positive results found in some cases of autoimmune haemolytic anaemia. Red cells from several patients with autoimmune haemolytic anaemia were tested with the above anticomplement sera, and serological results similar to those seen in the seven patients above were observed.
The antisera used in the study were potent reagents, for example, the anti-C4d/3d serum gave a titre of 2048 with control C3d/4d cells. The monospecific reagents also gave high titres with specific complement-coated control cells. At (Graham et al., 1976; Rosenfield and Jagathambal, 1978; Freedman and Massey, unpublished observations) , and this normally present C3d may vary in amount in different normal, healthy individuals. It is felt, however, that the positive direct antiglobulin tests due to anticomplement described in the above patients are due to abnormal amounts of complement deposited on red cells and may be early markers of autoimmune disease.
The positive antiglobulin reactions observed in the hospital patients did not appear to be due to species antibodies, NIC, or other clinically insignificant cold antibodies or to drugs. Since no C3b or C4b was detected on the red cells, the positive reactions were probably due to red cell sensitisation in vivo rather than in vitro. It is suggested, therefore, that false-positive direct antiglobulin reactions should not be lightly dismissed and that patients should be further followed for other markers of autoimmune disease.
